Amber S. Kleckner, Eva Culakova, Takeshi Uemura, Jason Zittel, Brian L. Burnette, Thomas Bradley, Supriya G. Mohile. Published: June 14, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.06.002
September 5, 2022 Is the Modified Frailty Index useful in patients with metastatic lung cancer? Frailty involves the impairment of physiologic reserve and ability to maintain homeostasis following a stressor. It is a poor prognostic factor in adults with cancer, but the method used to define frailty has been a moving target.1 In research settings, different definitions used include the phenotypic Fried criteria, a deficit accumulation model defined by a frailty index, or deficits on a comprehensive geriatric assessment.2,3,4 Each of these definitions has integration challenges in a clinical setting. The Modified Frailty Index (mFI) is a brief tool that correlates with post-operative morbidity and mortality in surgical populations.5,6,7 The importance of frailty in patients with metastatic non-small cell lung cancer (NSCLC) receiving chemotherapy remains unclear and the correlation of the mFI with outcomes in this population was unknown. As part of a project [...]
Organized by the SIOG Nursing, Allied Health and Scientists Interest Group June 16, 2022 Diana Withrow, MD https://vimeo.com/722216125
June 20, 2022 Journal of Cachexia, Sarcopenia, and Muscle - 2022 Feb;13(1):264-275. doi: 10.1002/jcsm.12871. Sarcopenia is a progressive loss of muscle function and mass that is mostly related to aging [1]. Due to sarcopenia’s adverse outcomes in several conditions, diagnosis and integration into treatment plans is highly recommended [1]. In the care of older adults, cognitive impairment, functional decline, or acute life-threatening medical conditions, such as severe pneumonia, myocardial infarctions, or highly proliferative hematological conditions can preclude patients from self-reported assessment. In addition, a severe acute condition can lead to a massive functional decline within a short time-frame. Thus, physical resilience can be underestimated if a superior premorbid condition is not known to the treating physician. To overcome these barriers, the authors aimed to validate the SARC-F questionnaire, a broadly used screening questionnaire for severe sarcopenia-related functional impairments [2], for the use of proxy-reported information [...]
Yacki Hayashi-Tanner, Peter J. Polewski, Mamatha Gaddam, Nancy R. Fisher, Attila J. Kovacs, David E. Marinier. Published: May 28, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.05.007
Qian Sun, Xiaohan Jiang, Rui Qin, Yuanyuan Yang, Yabo Gong, Kunyuan Wang, Junsheng Peng. Published: May 26, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.03.008
T.E. Argillander, H.C. van der Hulst, H.J. van der Zaag-Loonen, P. van Duijvendijk, J.W.T. Dekker, J.M. van der Bol, E. Bastiaannet, J. Verkuyl, P. Neijenhuis, M. Hamaker, A.H. Schiphorst, T.S. Aukema, T.A. Burghgraef, D.J.A. Sonneveld, J.S. Schuijtemaker, W. van der Meij, F. van den Bos, J.E.A. Portielje, E.T.D. Souwer, B.C. van Munster. Published: May 19, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.05.004
Gabrielle R. Sena, Jurema T.O. Lima, Tiago P.F. Lima, Suely A. Vidal, Mozart J.T. Sales, Paulo S.A. Goes, Maria Julia G. Mello. Published: May 16, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.05.003
Kumud Kantilal, Kavita Kantilal, Ginah Nightingale, Erika Ramsdale. Published: June 08, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.05.012
Hande Sungur, Maria E.T.C. van den Muijsenbergh, Julia C.M. van Weert, Barbara C. Schouten, Published: May 16, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.04.009
International Society of Geriatric Oncology
P/A Comptabilis
9 route des Jeunes
1227 Les Acacias - Switzerland
In Special Consultative Status with the United Nations Economic and Social Council (ECOSOC).
Powered by K.I.T. Group – Crafted for Excellence
